Browsing Tag
American Society of Clinical Oncology Gastrointestinal Cancer Symposium
1 post
Pfizer’s BRAFTOVI regimen doubles response rates for metastatic colorectal cancer
Pfizer Inc. has unveiled compelling findings from the Phase 3 BREAKWATER trial, highlighting the efficacy of its BRAFTOVI…